EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Efficacy and Safety of TACE-HAIC Combined with Molecular Targeted Therapy and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma

Zhipeng Feng iD, Xiaolong Wang iD, Junming Xu, Shiguang Chen iD, Mingzhi Hao iD, Hong Hu, Shixiang Qiu, Yunguo Liao, Wenchang Yu iD, Zhuting Fang

Journal of Hepatocellular Carcinoma · 2026-05 · Volume 13 · 1-12

DOI: 10.2147/jhc.s588860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-05. Verfasst von Zhipeng Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Vascular Interventional Therapy, Clinical Oncology School of Fujian Medical University, Fujan Cancer Hospital, NHC Key Lab…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

hepatic arterial infusion chemotherapyhepatocellular carcinomaimmune checkpoint inhibitorsmolecular targeted therapytransarterial chemoembolization

Autor:innen und Institutionen

  • Department of Oncology and Vascular Interventional Therapy, Clinical Oncology School of Fujian Medical University, Fujan Cancer Hospital, NHC Key Laboratory of Cancer Metabolism, Fuzhou, 350001, People's Republic of Chi…
  • Department of Interventional Medicine, Beijing Anzhen Nanchong Hospital, Capital Medical University & Nanchong Central Hospital, Nanchong, 637000, People's Republic of China.
  • Department of Vascular and Oncology Intervention, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, 350001, People's Rep…

ORCID-Profile: Zhipeng Feng, Xiaolong Wang, Shiguang Chen, Mingzhi Hao, Wenchang Yu

Zitieren

APA

Feng, Z., Wang, X., Xu, J., Chen, S., Hao, M., Hu, H., Qiu, S., Liao, Y., Yu, W., & Fang, Z. (2026). Efficacy and Safety of TACE-HAIC Combined with Molecular Targeted Therapy and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, Volume 13, 1-12. https://doi.org/10.2147/jhc.s588860

Vancouver

Feng Z, Wang X, Xu J, Chen S, Hao M, Hu H, et al. Efficacy and Safety of TACE-HAIC Combined with Molecular Targeted Therapy and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-12. doi:10.2147/jhc.s588860

BibTeX
@article{Feng2026,
  author = {Feng, Zhipeng and Wang, Xiaolong and Xu, Junming and Chen, Shiguang and Hao, Mingzhi and Hu, Hong and Qiu, Shixiang and Liao, Yunguo and Yu, Wenchang and Fang, Zhuting},
  title = {Efficacy and Safety of TACE-HAIC Combined with Molecular Targeted Therapy and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--12},
  doi = {10.2147/jhc.s588860}
}
Kostenlos starten →